{"id":"https://openalex.org/W2108011111","doi":"https://doi.org/10.1016/j.schres.2013.06.041","title":"Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study","display_name":"Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-24","ids":{"openalex":"https://openalex.org/W2108011111","doi":"https://doi.org/10.1016/j.schres.2013.06.041","mag":"2108011111","pmid":"https://pubmed.ncbi.nlm.nih.gov/23890595"},"language":"en","primary_location":{"id":"doi:10.1016/j.schres.2013.06.041","doi":"https://doi.org/10.1016/j.schres.2013.06.041","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.schres.2013.06.041","pdf_url":null,"source":{"id":"https://openalex.org/S144105592","display_name":"Schizophrenia Research","issn_l":"0920-9964","issn":["0920-9964","1573-2509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophrenia Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2108011111"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.schres.2013.06.041","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086932538","display_name":"Suresh Mallikaarjun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Suresh Mallikaarjun","raw_affiliation_strings":["Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA. Electronic address: suresh.mallikaarjun@otsuka-us.com","Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA. Electronic address: suresh.mallikaarjun@otsuka-us.com","institution_ids":["https://openalex.org/I4405268153"]},{"raw_affiliation_string":"Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004031088","display_name":"John Michael Kane","orcid":"https://orcid.org/0000-0002-2628-9442","observed_orcids":["https://orcid.org/0000-0002-2628-9442"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]},{"id":"https://openalex.org/I4210166545","display_name":"Zucker Hillside Hospital","ror":"https://ror.org/05vh9vp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John M. Kane","raw_affiliation_strings":["Zucker Hillside Hospital and The Albert Einstein College of Medicine, Glen Oaks, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zucker Hillside Hospital and The Albert Einstein College of Medicine, Glen Oaks, NY, USA","institution_ids":["https://openalex.org/I129975664","https://openalex.org/I4210166545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084991363","display_name":"Patricia Bricmont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia Bricmont","raw_affiliation_strings":["Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108358185","display_name":"Robert D. McQuade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert McQuade","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036492697","display_name":"William H. Carson","orcid":"https://orcid.org/0000-0002-8876-9556","observed_orcids":["https://orcid.org/0000-0002-8876-9556"]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William Carson","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045081626","display_name":"Raymond Sanchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raymond Sanchez","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110034011","display_name":"Robert A. Forbes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A. Forbes","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc. Princeton, NJ, USA","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112730977","display_name":"W. Wolfgang Fleischhacker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143397708","display_name":"Innsbruck Medical University","ror":"https://ror.org/03pt86f80","country_code":"AT","type":"education","lineage":["https://openalex.org/I143397708"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Wolfgang Fleischhacker","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy, Medical University Innsbruck , Austria ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy, Medical University Innsbruck , Austria ;","institution_ids":["https://openalex.org/I143397708"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3910,"currency":"USD","value_usd":3910},"apc_paid":{"value":3910,"currency":"USD","value_usd":3910},"fwci":4.5015,"has_fulltext":false,"cited_by_count":114,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9509179,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"150","issue":"1","first_page":"281","last_page":"288"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole-once-monthly","display_name":"aripiprazole once-monthly","score":0.9869999885559082},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.9892998933792114},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8339521884918213},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6735029220581055},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6192783713340759},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.5054717063903809},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.49371013045310974},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4481043219566345},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4349100887775421},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4290789067745209},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.42107725143432617},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4090656638145447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35294216871261597},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.34811776876449585},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.13451233506202698}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.schres.2013.06.041","doi":"https://doi.org/10.1016/j.schres.2013.06.041","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.schres.2013.06.041","pdf_url":null,"source":{"id":"https://openalex.org/S144105592","display_name":"Schizophrenia Research","issn_l":"0920-9964","issn":["0920-9964","1573-2509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophrenia Research","raw_type":"journal-article"},{"id":"pmid:23890595","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23890595","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophrenia research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1016/j.schres.2013.06.041","doi":"https://doi.org/10.1016/j.schres.2013.06.041","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.schres.2013.06.041","pdf_url":null,"source":{"id":"https://openalex.org/S144105592","display_name":"Schizophrenia Research","issn_l":"0920-9964","issn":["0920-9964","1573-2509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","erih-plus","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schizophrenia Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W173989890","https://openalex.org/W1919551764","https://openalex.org/W1968098502","https://openalex.org/W1986060217","https://openalex.org/W1989418652","https://openalex.org/W1999689270","https://openalex.org/W2004692455","https://openalex.org/W2018295858","https://openalex.org/W2020615571","https://openalex.org/W2033155032","https://openalex.org/W2037650878","https://openalex.org/W2055465804","https://openalex.org/W2059403801","https://openalex.org/W2069024810","https://openalex.org/W2076607047","https://openalex.org/W2083770042","https://openalex.org/W2088044851","https://openalex.org/W2102101987","https://openalex.org/W2107962758","https://openalex.org/W2125094565","https://openalex.org/W2140606211","https://openalex.org/W2143267960","https://openalex.org/W2151492290","https://openalex.org/W2157408003","https://openalex.org/W2162820060","https://openalex.org/W2165379748","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2004692455","https://openalex.org/W4414703476","https://openalex.org/W2093507661","https://openalex.org/W4360807802","https://openalex.org/W1978778712","https://openalex.org/W4366716824","https://openalex.org/W2326853904","https://openalex.org/W2520241576","https://openalex.org/W3038782863","https://openalex.org/W4365511387"],"abstract_inverted_index":{"This":[0],"24-week,":[1],"open-label,":[2],"Phase":[3],"Ib,":[4],"parallel-arm,":[5],"multiple-dose":[6],"trial":[7],"assessed":[8],"the":[9,45,50,66,82,92,119,147,157,162],"pharmacokinetics,":[10],"safety":[11],"and":[12,41,62,70,85,109,150,165,226,241],"tolerability":[13],"of":[14,18,38,95,102,107,128,137,143,239,249],"a":[15,141,244],"once-monthly":[16,97,104,139,236],"injection":[17,84,210],"aripiprazole":[19,33,79,88,96,103,114,138,170,235],"(aripiprazole":[20],"once-monthly)":[21],"in":[22,178,185],"41":[23],"subjects":[24],"with":[25,91,118,161,169,251],"schizophrenia.":[26,252],"The":[27,197],"objective":[28],"was":[29],"to":[30,156],"determine":[31],"if":[32],"plasma":[34,115,133],"concentrations":[35,116,134],"(at":[36],"doses":[37,106,127,238],"200,":[39],"300":[40,68,108,163,206,222,229,240],"400mg)":[42,225],"were":[43,57,75,145,153,203],"within":[44],"therapeutic":[46,148],"range":[47,121,149],"observed":[48,122],"for":[49,65,98,247],"oral":[51,78,87,129],"tablet":[52],"(10-30":[53],"mg).":[54],"Completion":[55],"rates":[56],"36.4%":[58],"(n=4/11),":[59],"50.0%":[60],"(n=8/16)":[61],"71.4%":[63],"(n=10/14)":[64],"200mg,":[67],"mg":[69,164],"400mg":[71,110,166,242],"groups,":[72],"respectively.":[73],"Patients":[74],"stabilized":[76],"on":[77],"(10mg/day)":[80,89],"before":[81],"first":[83,93],"received":[86],"concomitantly":[90],"dose":[94,142,159],"14":[99],"days.":[100],"Administration":[101],"at":[105,140,172,237],"provided":[111],"sustained":[112],"mean":[113],"comparable":[117],"concentration":[120],"following":[123,135],"multiple":[124],"consecutive":[125],"daily":[126],"aripiprazole.":[130],"In":[131,233],"contrast,":[132],"administration":[136],"200mg":[144],"below":[146],"pharmacokinetic":[151],"parameters":[152],"not":[154,176],"proportional":[155],"administered":[158],"compared":[160],"doses.":[167],"Treatment":[168],"once-monthly,":[171],"any":[173,179],"dose,":[174],"did":[175],"result":[177],"clinically":[180],"meaningful":[181],"changes":[182],"from":[183],"baseline":[184],"extrapyramidal":[186],"symptom":[187],"scales,":[188],"clinical":[189],"laboratory":[190],"tests,":[191],"vital":[192],"signs,":[193],"or":[194],"electrocardiogram":[195],"parameters.":[196],"most":[198],"common":[199],"treatment-emergent":[200],"adverse":[201],"events":[202],"vomiting":[204],"(13.3%,":[205],"mg;":[207,223,230],"14.3%,":[208,224],"400mg),":[209,214],"site":[211],"pain":[212],"(28.6%,":[213],"upper":[215],"respiratory":[216],"tract":[217],"infection":[218],"(10%,":[219],"200mg;":[220],"6.7%":[221],"tremor":[227],"(6.7%,":[228],"21.4%,":[231],"400mg).":[232],"conclusion,":[234],"is":[243],"viable":[245],"formulation":[246],"treatment":[248],"adults":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2108011111","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
